How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

被引：0
|
作者：
Mikyung Kelly Seo
John Cairns
机构：
[1] London School of Hygiene and Tropical Medicine,Department of Health Services Research and Policy, Faculty of Public Health and Policy
[2] University of Bergen,Centre for Cancer Biomarkers (CCBIO)
[3] Department of Surgery and Cancer,undefined
[4] Faculty of Medicine,undefined
[5] Imperial College London,undefined
[6] Department of Public Health and Primary Care,undefined
[7] School of Clinical Medicine,undefined
[8] University of Cambridge,undefined
来源：
BMC Cancer | / 21卷
关键词：
Biomarker; Companion biomarker; Companion diagnostic; Precision medicine; Targeted therapy; Oncology; Cancer; Economic evaluation; Health economics; Cost-effectiveness; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review
    Seo, Mikyung Kelly
    Cairns, John
    [J]. BMC CANCER, 2021, 21 (01)
  • [2] Cost-effectiveness of targeted oncology therapies: A systematic literature review
    Kalpas, E.
    Doyle, J.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A325 - A326
  • [3] Targeted therapies for metastatic colorectal cancer (mCRC): A systematic review of cost-effectiveness (CE).
    Bentley, Tanya G.
    Broder, Michael Samuel
    Das, Lopamudra
    Ortendahl, Jesse
    Su, Yun
    Wagner, Samuel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [4] A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer
    Lange, A.
    Prenzler, A.
    Frank, M.
    Golpon, H.
    von der Schulenburg, Graf J-M
    [J]. ONKOLOGIE, 2013, 36 : 251 - 251
  • [5] An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer
    Gogate, Anagha
    Rotter, Jason S.
    Trogdon, Justin G.
    Meng, Ke
    Baggett, Christopher D.
    Reeder-Hayes, Katherine E.
    Wheeler, Stephanie B.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 343 - 355
  • [6] An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer
    Anagha Gogate
    Jason S. Rotter
    Justin G. Trogdon
    Ke Meng
    Christopher D. Baggett
    Katherine E. Reeder-Hayes
    Stephanie B. Wheeler
    [J]. Breast Cancer Research and Treatment, 2019, 174 : 343 - 355
  • [7] A SYSTEMATIC REVIEW EVALUATING COST-EFFECTIVENESS OF ACUPUNCTURE
    Kim, S. Y.
    Lee, H.
    Park, H. J.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A255 - A255
  • [8] A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
    Lange, Ansgar
    Prenzler, Anne
    Frank, Martin
    Golpon, Heiko
    Welte, Tobias
    von der Schulenburg, J-Matthias
    [J]. BMC PULMONARY MEDICINE, 2014, 14
  • [9] A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
    Ansgar Lange
    Anne Prenzler
    Martin Frank
    Heiko Golpon
    Tobias Welte
    J-Matthias von der Schulenburg
    [J]. BMC Pulmonary Medicine, 14
  • [10] COST-EFFECTIVENESS OF TARGETED PHARMACOTHERAPY - A SYSTEMATIC REVIEW OF THE LITERATURE
    Amler, N.
    Becker, T.
    Bierbaum, M.
    Schoeffski, O.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A407 - A407
12345